Sectors
PDSB
PDS Biotechnology Corporation
0.26
12 x 0.25
5 x 0.27
bid
ask
-
0.47
64.87%
5500 @ 04:00 PM
0.26 +0.00 (1.29%)
| Ytd | -66.65% | |
| 1y | -76.22% |
0.23
day range
0.68
0.23
52 week range
1.55
| Open | 0.68 | Prev Close | 0.73 | Low | 0.23 | High | 0.68 | Mkt Cap | 14.36M |
| Vol | 26.75M | Avg Vol | 653.69K | EPS | -0.67 | P/E | -0.38 | Forward P/E | -1.18 |
| Beta | 1.93 | Short Ratio | 10.47 | Inst. Own | 12.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.86 | 200-d Avg | 0.88 | 1yr Est | 11.50 |
| Income Statement | |||
| Operating Expenses | 6.52M | ||
| Research and Development Expense | 3.46M | ||
| Selling, General and Administrative Expense | 3.06M | ||
| Operating Income | -6.52M | ||
| Interest Expense | 827.97K | ||
| Net Income | -7.35M | ||
| Net Income Common Stock | -7.35M | ||
| Net Income Common Stock (USD) | -7.35M | ||
| Consolidated Income | -7.35M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -6.52M | ||
| Earning Before Interest & Taxes (USD) | -6.52M | ||
| Weighted Average Shares | 55.50M | ||
| Weighted Average Shares Diluted | 55.50M | ||
| Balance Sheet | |||
| Cash and Equivalents | 21.66M | ||
| Cash and Equivalents (USD) | 21.66M | ||
| Current Assets | 22.89M | ||
| Property, Plant & Equipment Net | 228.57K | ||
| Total Assets | 24.66M | ||
| Debt Current | 5.24M | ||
| Total Debt | 15.86M | ||
| Current Liabilities | 10.15M | ||
| Debt Non-Current | 10.62M | ||
| Total Liabilities | 20.77M | ||
| Accumulated Retained Earnings (Deficit) | -223.96M | ||
| Shareholders Equity | 3.89M | ||
| Shareholders Equity (USD) | 3.89M | ||
| Assets Non-Current | 1.78M | ||
| Total Debt (USD) | 15.86M | ||
| Liabilities Non-Current | 10.62M | ||
| Trade and Non-Trade Payables | 3.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 15.13K | ||
| Net Cash Flow from Financing | -679.83K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.05M | ||
| Issuance (Purchase) of Equity Shares | 833.37K | ||
| Issuance (Repayment) of Debt Securities | -1.51M | ||
| Net Cash Flow from Operations | -4.37M | ||
| Share Based Compensation | 1.16M | ||